Skip to main content
The Peter Attia Drive

#416 ‒ The science of mitochondria: their role in health, aging, and disease, and what the evidence says about drugs and supplements aimed at improving their function | Navdeep Chandel, Ph.D.

126 min episode · 3 min read
·
Navdeep Chandel

Episode

126 min

Read time

3 min

Topics

Productivity, Health & Wellness, Product & Tech Trends

AI-Generated Summary

Key Takeaways

  • ✓Mitochondrial signaling hierarchy: Mitochondria perform three functions beyond ATP production that matter more for aging and disease: generating H2O2 for immune cell signaling and differentiation, supplying TCA cycle metabolites like alpha-ketoglutarate that control 75 epigenetic enzymes, and releasing mitochondrial DNA/RNA to activate interferon-based immune responses. Chandel argues most "mitochondrial dysfunction" discourse focuses exclusively on ATP, missing these higher-order communication roles entirely.
  • ✓Antioxidant supplementation backfires: High-dose antioxidant supplementation can impair immune function by neutralizing the H2O2 signals mitochondria use to generate memory T cells and coordinate immune responses. Clinical trials in sepsis worsened outcomes with antioxidants. Selenium deficiency is the one legitimate exception, relevant in low-selenium regions like parts of Scandinavia and New Zealand. Two oranges daily provides sufficient vitamin C to run all 75 alpha-ketoglutarate-dependent epigenetic enzymes.
  • ✓Zone 2 as mitochondrial function test: The most practical, non-invasive mitochondrial function assessment is measuring sustainable power output in watts while keeping blood lactate below 2 mmol/L. This lactate threshold one test, performed on a bike or treadmill, reflects mitochondrial oxidative capacity without requiring muscle biopsy. Elite cyclists like Tadej Pogačar sustain roughly 350 watts at this threshold versus approximately 230 watts for a trained non-professional, illustrating the performance gap mitochondrial efficiency creates.
  • ✓Metformin's mechanism is gut-centric, not liver-centric: C-11 PET imaging shows metformin concentrates at roughly 1 millimolar in the gut, drops to 50 micromolar in the liver, and reaches only 10 micromolar in blood. It inhibits mitochondrial complex I in intestinal cells, triggering GLP-1 and GDF-15 release, blunting postprandial glucose spikes, and lowering circulating citrulline. Taking metformin 30 minutes before meals maximizes this gut-mediated glucose-lowering effect. B12 and citrulline supplementation can offset its two main nutritional side effects.
  • ✓Metformin's anti-cancer mechanism requires a transporter: Metformin's anticancer effects depend entirely on whether tumor cells express organic cation transporters (OCT1-3). Cells lacking these transporters show complete metformin resistance regardless of dose. Cancer trials have never stratified patients by OCT status, which likely explains clinical trial failures in breast and prostate cancer. Tumors that shift from FDG-PET negative to positive after metformin dosing would confirm transporter presence and predict treatment response, offering a viable patient-selection strategy.

What It Covers

Peter Attia and Northwestern mitochondria researcher Navdeep Chandel examine what mitochondria actually do beyond ATP production, covering three core signaling functions, why mitochondrial dysfunction is frequently misdiagnosed in aging, how metformin operates primarily through gut-based complex I inhibition, and what the evidence actually supports for popular mitochondrial supplements including urolithin A and berberine.

Key Questions Answered

  • •Mitochondrial signaling hierarchy: Mitochondria perform three functions beyond ATP production that matter more for aging and disease: generating H2O2 for immune cell signaling and differentiation, supplying TCA cycle metabolites like alpha-ketoglutarate that control 75 epigenetic enzymes, and releasing mitochondrial DNA/RNA to activate interferon-based immune responses. Chandel argues most "mitochondrial dysfunction" discourse focuses exclusively on ATP, missing these higher-order communication roles entirely.
  • •Antioxidant supplementation backfires: High-dose antioxidant supplementation can impair immune function by neutralizing the H2O2 signals mitochondria use to generate memory T cells and coordinate immune responses. Clinical trials in sepsis worsened outcomes with antioxidants. Selenium deficiency is the one legitimate exception, relevant in low-selenium regions like parts of Scandinavia and New Zealand. Two oranges daily provides sufficient vitamin C to run all 75 alpha-ketoglutarate-dependent epigenetic enzymes.
  • •Zone 2 as mitochondrial function test: The most practical, non-invasive mitochondrial function assessment is measuring sustainable power output in watts while keeping blood lactate below 2 mmol/L. This lactate threshold one test, performed on a bike or treadmill, reflects mitochondrial oxidative capacity without requiring muscle biopsy. Elite cyclists like Tadej Pogačar sustain roughly 350 watts at this threshold versus approximately 230 watts for a trained non-professional, illustrating the performance gap mitochondrial efficiency creates.
  • •Metformin's mechanism is gut-centric, not liver-centric: C-11 PET imaging shows metformin concentrates at roughly 1 millimolar in the gut, drops to 50 micromolar in the liver, and reaches only 10 micromolar in blood. It inhibits mitochondrial complex I in intestinal cells, triggering GLP-1 and GDF-15 release, blunting postprandial glucose spikes, and lowering circulating citrulline. Taking metformin 30 minutes before meals maximizes this gut-mediated glucose-lowering effect. B12 and citrulline supplementation can offset its two main nutritional side effects.
  • •Metformin's anti-cancer mechanism requires a transporter: Metformin's anticancer effects depend entirely on whether tumor cells express organic cation transporters (OCT1-3). Cells lacking these transporters show complete metformin resistance regardless of dose. Cancer trials have never stratified patients by OCT status, which likely explains clinical trial failures in breast and prostate cancer. Tumors that shift from FDG-PET negative to positive after metformin dosing would confirm transporter presence and predict treatment response, offering a viable patient-selection strategy.
  • •Clonal hematopoiesis and inflammation as metformin targets: Three simultaneous Nature-level papers demonstrated that metformin inhibits clonal hematopoiesis of indeterminate potential (CHIP) via complex I inhibition in hematopoietic stem cells, with supporting correlation data from 450,000 UK Biobank participants. Separately, metformin given in drinking water to mice exposed to PM2.5 pollution blocked IL-6 production in alveolar macrophages through the same complex I pathway. These two inflammation-related mechanisms represent the strongest current rationale for metformin use in metabolically healthy individuals.
  • •Urolithin A's mechanism remains unestablished: Urolithin A is rapidly conjugated by the liver into a glucuronide form that cannot enter cells, leaving only picogram-level free urolithin detectable in plasma after oral supplementation. No published study has identified a molecular target explaining its purported mitophagy-inducing effects, and no labeled-compound biodistribution study has confirmed tissue uptake. Until a cellular target is identified and a transporter-refractory model validates the mechanism, the evidence base for urolithin A supplementation remains mechanistically incomplete despite observed in vitro mitophagy signals.

Notable Moment

Chandel describes a mouse experiment where the heart's electron transport chain was genetically disabled, yet the organ continued pumping for months using glycolysis alone. The heart eventually failed not from energy deprivation but from hypertrophy triggered by downstream signaling gone wrong — revealing that mitochondrial dysfunction kills through miscommunication, not simply by running out of fuel.

Know someone who'd find this useful?

Episode Transcript

Hey, everyone. Welcome to the Drive podcast. I'm your host, Peter Attia. This podcast, my website, and my weekly newsletter all focus on the goal of translating the science of longevity into something accessible for everyone. Our goal is to provide the best content in health and wellness, and we've established a great team of analysts to make this happen. It is extremely important to me to provide all of this content without relying on paid ads. To do this, our work is made entirely possible by our members, and in return, we offer exclusive member only content and benefits above and beyond what is available for free. If you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of the subscription. If you want to learn more about the benefits of our premium membership, head over to peteratiamd.com forward slash subscribe. My guest this week is Nav Chandel returning for his second conversation on The Drive. I believe Nav was on in late twenty eighteen or early twenty nineteen. Nav is a distinguished professor of medicine, biochemistry and molecular genetics at Northwestern University where he studies mitochondrial biology and the role mitochondria play in aging and chronic disease. He's one of the most thoughtful scientists I know in this space, especially when it comes to separating what we think we know about mitochondria from what the data actually support. And of course everybody knows that mitochondria is almost a laughable buzzword at this point in health circles. So I thought it would be really important to have on the world's expert on this topic so that we could separate signal from noise. In this episode we discuss what mitochondria actually do beyond ATP production, which I think is what everybody understands. Why their real job is often misunderstood. How mitochondria regulate signaling through reactive oxygen species and why that matters for immune function. The role of mitochondrial metabolites in epigenetics, gene regulation and cellular adaptation. How mitochondrial DNA can trigger inflammation and how that intersects with aging. What mitochondrial dysfunction really means and why it's often used too loosely in aging conversations. Why metformin remains one of the most interesting drugs from mitochondrial biology despite decades of use, how metformin actually behaves in the body including its distribution, tissue level effects and gut centric mechanisms, the relationship between mitochondria inflammation and environmental stressors like pollution, a practical rundown of popular mitochondrial supplements and what NAV thinks the evidence does and doesn't support for each of them, where compounds like Urolithin A and alpha ketoglutarate fit in under this broader mitochondrial conversation, the mechanistic appeal and real world limitations of interventions like methylene blue and hyperbaric oxygen. Going into this podcast, I thought I understood most of what the mitochondria did and I have to say I came out of this scribbling down many notes realizing that my own understanding of this space expanded …

Get the full transcript (22,715 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all The Peter Attia Drive transcripts →

You just read a 3-minute summary of a 123-minute episode.

Get The Peter Attia Drive summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from The Peter Attia Drive

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Health Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into The Peter Attia Drive.

Every Monday, we deliver AI summaries of the latest episodes from The Peter Attia Drive and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime